James Walters

Health and Wellbeing Board - Thursday, 10 September 2026 - 2.00 pm

Health and Wellbeing Board - Thursday 2 July 2026 2.00 pm

The Health and Wellbeing Board met on Thursday 2 July 2026 to discuss the implementation of the Neighbourhood Health model, with a particular focus on frailty, and to review the Better Care Fund performance and plans. The Board agreed to continue focusing on frailty within Integrated Neighbourhood Teams (INTs) and approved the forward plan for future board meetings. They also noted and approved the 2025/26 Better Care Fund end-of-year report and the proposals for the 2026/27 Better Care Fund plan.

Health and Wellbeing Board - Thursday 12 March 2026 2.00 pm

The Health and Wellbeing Board met on Thursday 12 March 2026 to discuss a range of critical public health issues. Key decisions included endorsing actions to combat rising tuberculosis rates, noting progress on early homelessness prevention, and agreeing to continue developing the Joint Strategic Needs Assessment. The Board also received updates on the Community Equipment Service and the ongoing consultation regarding the Mount Vernon Cancer Centre.

Health and Wellbeing Board - Thursday 8 January 2026 2.00 pm, NEW

The Health and Wellbeing Board of Harrow Council met on Thursday 08 January 2026 to discuss winter preparedness, a whole systems approach to weight management, and support for residents with severe and multiple disadvantages. Key decisions included noting the winter preparedness framework, endorsing the whole systems approach to healthy weight, and agreeing to further investigate support for residents with severe and multiple disadvantages.

Health and Wellbeing Board - Thursday 11 September 2025 2.00 pm

The Health and Wellbeing Board met on Thursday 11 September 2025 to discuss the council's response to a recent Ofsted inspection of children's services, the Harrow Safeguarding Adult Board's annual report, and the Pharmaceutical Needs Assessment. Key decisions included noting the findings of the Ofsted inspection and approving the Pharmaceutical Needs Assessment for publication.